Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transfusion of prion-filtered red cells does not increase the rate of alloimmunization or transfusion reactions in patients: results of the UK trial of prion-filtered versus standard red cells in surgical patients (PRISM A).
Elebute MO, Choo L, Mora A, MacRury C, Llewelyn C, Purohit S, Hicks V, Casey C, Malfroy M, Deary A, Reed T, Meredith S, Manson L, Williamson LM. Elebute MO, et al. Among authors: choo l. Br J Haematol. 2013 Mar;160(5):701-8. doi: 10.1111/bjh.12188. Epub 2013 Jan 7. Br J Haematol. 2013. PMID: 23294293 Free article. Clinical Trial.
The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial.
Howard J, Malfroy M, Llewelyn C, Choo L, Hodge R, Johnson T, Purohit S, Rees DC, Tillyer L, Walker I, Fijnvandraat K, Kirby-Allen M, Spackman E, Davies SC, Williamson LM. Howard J, et al. Among authors: choo l. Lancet. 2013 Mar 16;381(9870):930-8. doi: 10.1016/S0140-6736(12)61726-7. Epub 2013 Jan 23. Lancet. 2013. PMID: 23352054 Clinical Trial.
Cost-effectiveness analysis of preoperative transfusion in patients with sickle cell disease using evidence from the TAPS trial.
Spackman E, Sculpher M, Howard J, Malfroy M, Llewelyn C, Choo L, Hodge R, Johnson T, Rees DC, Fijnvandraat K, Kirby-Allen M, Davies S, Williamson L. Spackman E, et al. Among authors: choo l. Eur J Haematol. 2014 Mar;92(3):249-55. doi: 10.1111/ejh.12232. Epub 2013 Dec 12. Eur J Haematol. 2014. PMID: 24329965 Free PMC article. Clinical Trial.
An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial.
Marsh JC, Stanworth SJ, Pankhurst LA, Kallon D, Gilbertson AZ, Pigden C, Deary AJ, Mora AS, Brown J, Laing ES, Choo LL, Hodge R, Llewelyn CA, Harding K, Sage D, Mijovic A, Mufti GJ, Navarrete CV, Brown CJ. Marsh JC, et al. Among authors: choo ll. Blood. 2021 Jan 21;137(3):310-322. doi: 10.1182/blood.2020007199. Blood. 2021. PMID: 33475737 Free article. Clinical Trial.
A randomized noninferiority crossover trial of corrected count increments and bleeding in thrombocytopenic hematology patients receiving 2- to 5- versus 6- or 7-day-stored platelets.
MacLennan S, Harding K, Llewelyn C, Choo L, Bakrania L, Massey E, Stanworth S, Pendry K, Williamson LM. MacLennan S, et al. Among authors: choo l. Transfusion. 2015 Aug;55(8):1856-65; quiz 1855. doi: 10.1111/trf.13038. Epub 2015 Feb 27. Transfusion. 2015. PMID: 25727713 Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 33067624
Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.
Stanworth SJ, Dyer C, Choo L, Bakrania L, Copplestone A, Llewelyn C, Norfolk D, Powter G, Littlewood T, Wood EM, Murphy MF; TOPPS Study Group. Stanworth SJ, et al. Among authors: choo l. Transfus Med Rev. 2010 Jul;24(3):163-71. doi: 10.1016/j.tmrv.2009.11.002. Transfus Med Rev. 2010. PMID: 20656185 Review.
A no-prophylaxis platelet-transfusion strategy for hematologic cancers.
Stanworth SJ, Estcourt LJ, Powter G, Kahan BC, Dyer C, Choo L, Bakrania L, Llewelyn C, Littlewood T, Soutar R, Norfolk D, Copplestone A, Smith N, Kerr P, Jones G, Raj K, Westerman DA, Szer J, Jackson N, Bardy PG, Plews D, Lyons S, Bielby L, Wood EM, Murphy MF; TOPPS Investigators. Stanworth SJ, et al. Among authors: choo l. N Engl J Med. 2013 May 9;368(19):1771-80. doi: 10.1056/NEJMoa1212772. N Engl J Med. 2013. PMID: 23656642 Free article. Clinical Trial.
Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma.
Chapman CE, Stainsby D, Jones H, Love E, Massey E, Win N, Navarrete C, Lucas G, Soni N, Morgan C, Choo L, Cohen H, Williamson LM; Serious Hazards of Transfusion Steering Group. Chapman CE, et al. Among authors: choo l. Transfusion. 2009 Mar;49(3):440-52. doi: 10.1111/j.1537-2995.2008.01948.x. Epub 2008 Oct 28. Transfusion. 2009. PMID: 18980623
Prevalence of maternal anaemia and its predictors: a multi-centre study.
Barroso F, Allard S, Kahan BC, Connolly C, Smethurst H, Choo L, Khan K, Stanworth S. Barroso F, et al. Among authors: choo l. Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):99-105. doi: 10.1016/j.ejogrb.2011.07.041. Epub 2011 Sep 3. Eur J Obstet Gynecol Reprod Biol. 2011. PMID: 21890259
109 results